Condition category
Nutritional, Metabolic, Endocrine
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status
Results overdue

Plain English Summary

Background and study aims
Hypovitaminosis D (a deficiency in Vitamin D, a nutrient that comes from sunlight) has been associated with anemia in patients with chronic diseases and also in healthy populations. One of the explanations for this association is the action of vitamin D on iron metabolism, which influences the absorption and mobilisation of iron, mainly through inflammatory mechanisms. It is not yet known if vitamin D could directly influence the body iron storage. The aim of this study was to verify the correlation between vitamin D levels and body iron store in a population of healthy adult women.

Who can participate?
Women aged 18 and older with chronic diseases.

What does the study involve?
Participants are measured for their body iron content and their vitamin D levels measured which is retrieved from a public database. The data is then analysed using a statistical model.

What are the possible benefits and risks of participating?
There are no benefits or risks with participating.

Where is the study run from?
Instituto De Medicina Integral Professor Fernando Figueira (Brazil)

When is the study starting and how long is it expected to run for?
November 2016 to December 2016

Who is funding the study?
Investigator initiated and funded (Brazil)

Who is the main contact?
Mrs Daneily Barbosa

Trial website

Contact information



Primary contact

Mrs Daniely Barbosa


Contact details

Rua Arlindo Gouveia
+55 819 883 73784

Additional identifiers

EudraCT number number

Protocol/serial number

Plataforma Brasil. CAAE: 60849916.3.0000.5201

Study information

Scientific title

Influence of vitamin D on body iron store in healthy women from NHANES: a cross-sectional study using an econometric model of causal inference


Study hypothesis

1. Vitamin D levels have a positive correlation with body iron content in women.
2. Positive correlation functions between vitamin D levels and body iron content differ according to age, race, menstrual status and levels of parathyroid hormone.
3. Vitamin D has a cause-effect relationship on body iron content.

Ethics approval

Ethics Committee on Research in Human Beings of the Institute of Integral Medicine, 05/12/2016, ref: Record number: 60849916.3.00005201

Study design

A cross-sectional population-based study

Primary study design


Secondary study design

Cross sectional study

Trial setting


Trial type


Patient information sheet

No participant information sheet available.


Hypovitaminosis D and iron deficiency


The study is cross-sectional study. Participants have the variables of interested measured. This includes measurements for body iron content (calculated using Cook's formula) and 25hydroxivitamin D levels. There is no follow up. The data is retrieved from NHANES public datasets, which includes laboratory information of interest: levels of RsTf (soluble transferrin receptor), ferritin and 25hydroxivitamin D. No sample size calculation was performed, choosing to use all the observations that met the selection criteria in the years 2003-2004 and2005-2006.

Statistical analysis:
A predictive multivariate theoretical model, with Body Iron Store as dependent variable and 25 hydroxivitamin D as the predictive variable is designed. Statistical strategy to select covariables is not used, choosing, instead, saturated models that aim to estimate the coefficient of the predictive variable adjusted for the largest possible number of confounders. The following confounding covariables are: age, race, educational level, annual family income (USD/year), menstrual status, body mass index (BMI) (kg/m2), albumin level (g/dL), CRP level (mg/dL) and parathyroid hormone (PTH) level (pg/mL).

Initially, a simple linear regression model (Ordinary Least Squares – OLS) is used to evaluate the β coefficient of the correlation between 25OHD and BIS, which is then adjusted for sociodemographic, clinical, and laboratory covariables in a multiple linear regression model. For the evaluation of the possible effect modifiers, the model was stratified according to the subgroups of iron-sufficient and iron-deficient women. Next, vitamin D interaction terms, with age, race, PTH and menstrual status, are added, which are included in the multivariate models as products of 25OHD and each of these covariables.

Then, to access causal inference, we chose the econometric model proposed by Lewbel to identify the effect of endogeneity on dose-response correlation coefficients. According to the econometric rationale, if we can mathematically rule out the endogeneity bias, we can perform a causal inference.

Intervention type



Drug names

Primary outcome measure

Vitamin D levels in correlation with body iron stores (BIS) are measured using patient data and a predictive model.

Secondary outcome measures

There are no secondary outcome measures.

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Women older than 18 years old
2. Who did not have chronic diseases
3. In whom the results of 25-hydroxyvitamin D (25OHD)
4. Soluble transferrin receptor (sTfR)
5. Ferritin levels available
6. Chronic diseases as defined as the following a self-report of cancer, heart failure, pulmonary emphysema, chronic bronchitis, gastric or intestinal diseases; changes in laboratory markers of liver disease (aspartate aminotransferase greater than 121 U/L, alanine aminotransferase greater than 128 U/L and total bilirubin greater than 2.1 mg/dL) or renal disease (creatinine greater than 1.5 mg/dL); and the presence of a HIV-positive serology.

Participant type

Healthy volunteer

Age group




Target number of participants


Participant exclusion criteria

1. Women who reported undergoing iron supplementation in the last 3 months
2. Who had a positive pregnancy test or changes in the markers of malnutrition (albumin < 3.5 g/dL)
3. Inflammation (C-reactive protein (CRP) > 5.0 mg/dL) or iron overload (transferrin saturation > 45%)

Recruitment start date


Recruitment end date



Countries of recruitment

United States of America

Trial participating centre

Instituto De Medicina Integral Professor Fernando Figueira
R. dos Coelhos, 300 - Boa Vista PE

Sponsor information


Instituto De Medicina Integral Professor Fernando Figueira

Sponsor details

R. dos Coelhos
300 - Boa Vista

Sponsor type

Hospital/treatment centre



Funder type


Funder name

Investigator initated and funded

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Planned publication of the results in the American Journal of Clinical Nutrition.

IPD sharing statement:
The datasets generated during and/or analysed during the current study are/will be available upon request from Daniely Sobreira Cariry Barbosa (

Intention to publish date


Participant level data

Available on request

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes